Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04782817 · ClinicalTrials.gov registry record · NA
Reducing Reintubation Risk in High-Risk Cardiac Surgery Patients With High-Flow Nasal Cannula
A NA study of Intubation and Cardiovascular Surgical Procedure, sponsored by Vanderbilt University Medical Center.
- Active
- Registry status
- NA
- Development phase
- 3,568
- Enrollment target
- 1
- Study location
NCT04782817: Active NA study of Intubation and Cardiovascular Surgical Procedure, sponsored by Vanderbilt University Medical Center.
NCT04782817 is a NA study of Intubation and Cardiovascular Surgical Procedure that is active but no longer recruiting, run by Vanderbilt University Medical Center. The registered enrollment target is 3,568 participants, above the 1,990-participant average among 4 other Intubation trials with a reported enrollment target (79% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04782817, a NA study of Intubation and Cardiovascular Surgical Procedure, is active but no longer recruiting, sponsored by Vanderbilt University Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 3,568 participants
- Enrollment target
- 1
- Study location
Study Summary
The iCAN trial is a pragmatic randomized controlled trial that aims to test the hypothesis that HFNC versus usual care oxygenation strategies applied immediately after initial extubation after cardiac surgery decreases the all-cause 48-hour reintubation rate (extubation failure within 48 hours of initial extubation).
Primary Outcome
Reintubation within 48 hours of initial extubation after cardiac surgery
Conditions Studied
Interventions
- OTHER Recommendation for high flow nasal cannula oxygen therapy order set
- OTHER Provider choice standard care order set
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,568 participants |
| Start Date | 2021-11-01 |
| Est. Completion | 2026-03 |
| Phase | NA |
What the registry record for NCT04782817 still lists
NCT04782817 is an interventional study that assigns participants to a tested intervention. Its 3,568 participants enrollment target places it among the larger protocols in the corpus, above the 1,990-participant average among 4 other Intubation trials with a reported enrollment target (79% higher).
The record links to 2 conditions, with Intubation appearing as the primary indexed condition, and to 2 interventions - of which Recommendation for high flow nasal cannula oxygen therapy order set is the first listed.
NCT04782817 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT04782817 about?
NCT04782817 is a clinical study titled "Reducing Reintubation Risk in High-Risk Cardiac Surgery Patients With High-Flow Nasal Cannula". The iCAN trial is a pragmatic randomized controlled trial that aims to test the hypothesis that HFNC versus usual care oxygenation strategies applied immediately after initial extubation after cardiac surgery decreases the all-cause 48-hour reintubation rate (extubation failure within 48 hours of in...
What is the current status of trial NCT04782817?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 3,568 participants. The study started on 2021-11-01. Estimated completion is 2026-03.
What conditions does trial NCT04782817 study?
This clinical trial studies the following conditions: Intubation, Cardiovascular Surgical Procedure.
What interventions are being tested in trial NCT04782817?
The interventions under investigation include: Recommendation for high flow nasal cannula oxygen therapy order set (OTHER), Provider choice standard care order set (OTHER).
Who is sponsoring clinical trial NCT04782817?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04782817 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intubation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effects of Endotracheal Suctioning on Pain and Serum Markers
RECRUITING · NA
-
A Study Comparing Time to Intubate With and Without a Barrier Box
COMPLETED · NA
-
Assessment of an Oral Endotracheal Subglottic Tube Holder
COMPLETED · NA
-
Endotracheal Intubation Using Videolaryngoscopy Versus Conventional Direct Laryngoscopy
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06429787 · 3,574 participants
Post Marketing Observational Study on Safety of BALFAXAR vs. KCENTRA for Reversal of Vitamin K Antagonist Induced Anticoagulation in Adults Undergoing Urgent Surgery or Invasive Procedure
- NCT03199651 · 3,584 participants · NA
Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer
- NCT06088498 · 3,600 participants · Phase 2
App for Reducing Cravings to Smoke
- NCT06501118 · 3,600 participants · NA
Optimizing Care in Critically Ill at UCHealth by Liberalizing the Target O2 in Mechanically-ventilated ICU Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI